Safety and Function of Encapsulated Human Islets Transplanted Into People With Diabetes

South Eastern Sydney Illawarra Area Health Service0 个研究点目标入组 6 人开始时间: 2009年4月20日最近更新: 2020年1月13日

适应症

试验速览

暂无简介。

•normal body weight, that is, body mass index < 30, but ideally <25.
•(b) age 18-50 years
•(c) no insulin production from their pancreas
•(d) (i) difficulty in controlling blood glucose levels despite compliance with insulin injections, physical activity and food intake. This difficulty is impacting on the quality of life.
•(ii) unable to recognise the symptoms of low blood glucose levels for whom no other strategy has been successful.
•(iii) special situations, e.g., rapid falls in blood glucose levels resulting in epilepsy and where anti-epileptic medication is unsuitable.
•Each case will be considered on its merit, but the benefit must exceed the risk.

•1. Does not fit the above criteria.
•2. Residual function of recipient’s pancreatic beta cells, as assessed by C-peptide production.
•3. Body mass index > 30.
•4. Pregnancy.
•5. Non-agreement by patient’s endocrinologist.

发起方

South Eastern Sydney Illawarra Area Health Service